J. Hess

Haplotype-aware segmentation with HapASeg increases accuracy of detecting homolog-specific somatic copy number alterations.
20260 citationsauthor #5
Genomic landscape of multiple myeloma and its precursor conditions
202518 citationsauthor #34
SVelfie: A method for discovering cancer drivers based on enrichment of likely functional structural variants
20251 citationsauthor #6
Detection of heterogeneous resistance mechanisms to tyrosine kinase inhibitors from cell-free DNA
20250 citationsauthor #10
Patterns of hypermutation shape tumorigenesis and immunotherapy response in mismatch-repair-deficient glioma
20251 citationsauthor #9
Longitudinal whole exome sequencing of cell-free DNA in advanced bladder cancer.
20240 citationsauthor #9
Novel Non-Coding Candidate Drivers of Multiple Myeloma Linked to Plasma Cell Tumor Biology and B Cell Development
20242 citationsauthor #25
Abstract 4096: Comparative molecular profiling of sporadic and Lynch syndrome MSI tumors: Unraveling insights for vaccine design
20240 citationsauthor #3
A 1,000-Genome Map for Multiple Myeloma and Its Precursor Stages, and Its Impact on Clinical Outcome
20242 citationsauthor #27
Author Correction: Patterns of somatic structural variation in human cancer genomes
20234 citationsauthor #37
Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
20234 citationsauthor #37
Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
20231 citationsauthor #8
Author Correction: The evolutionary history of 2,658 cancers
20234 citationsauthor #504
Author Correction: Pan-cancer analysis of whole genomes
20238 citationsauthor #437
Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
20237 citationsauthor #71
Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers
20231 citationsauthor #455
Abstract 3874: Genomic mechanisms of resistance to tyrosine kinase inhibitors (TKIs) in HER2+ metastatic breast cancer (HER2+ MBC)
20233 citationsauthor #9
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome
202367 citationsauthor #37
Author Correction: The landscape of viral associations in human cancers
20231 citationsauthor #464
Genome Sequencing to Discover Drivers of Clonal Expansion in Smoldering Multiple Myeloma
20232 citationsauthor #16
Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
20231 citationsauthor #509
Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
20231 citationsauthor #34
Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial
2023136 citationsauthor #6
Author Correction: Patterns of somatic structural variation in human cancer genomes
20234 citationsauthor #512
Abstract 213: Phylogenetic reconstruction across 303 metastatic tumor samples using Ultima whole-genome sequencing dramatically increases subclonal resolution
20230 citationsauthor #1
Evolutionary History of Transformation from Chronic Lymphocytic Leukemia to Richter Syndrome
20222 citationsauthor #22
Author Correction: Pathway and network analysis of more than 2500 whole cancer genomes
20222 citationsauthor #55
Author Correction: Pathway and network analysis of more than 2500 whole cancer genomes
20222 citationsauthor #568
Author Correction: Inferring structural variant cancer cell fraction
20220 citationsauthor #514
Reconstructing the Genomic History of Multiple Myeloma Precursor Disease: Novel Insights and Clinical Applicability
20220 citationsauthor #7
Abstract 4007: Evolutionary history of transformation from chronic lymphocytic leukemia to Richter’s syndrome
20220 citationsauthor #26
The four mRNA bases have quite different (un)folding free energies, applications to RNA splicing and translation initiation with BindOligoNet.
20223 citationsauthor #1
Integrative pathway enrichment analysis of multivariate omics data
2020191 citationsauthor #43
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
2020212 citationsauthor #34
Butler enables rapid cloud-based analysis of thousands of human genomes
202011 citationsauthor #41
Author Correction: Cas9 activates the p53 pathway and selects for p53-inactivating mutations
20200 citationsauthor #8
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
202045 citationsauthor #26
Analyses of non-coding somatic drivers in , cancer whole genomes
20200 citationsauthor #8
Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis
2020155 citationsauthor #41
Patterns of somatic structural variation in human cancer genomes
2020686 citationsauthor #37
Patterns of somatic structural variation in human cancer genomes
2020686 citationsauthor #512
The CLL-1100 Project: Towards Complete Genomic Characterization and Improved Prognostics for CLL
20205 citationsauthor #12
Author Correction: Cas9 activates the p53 pathway and selects for p53-inactivating mutations
20209 citationsauthor #8
Apr 27, 2021 Pathway and network analysis of more than 2500
20200 citationsauthor #27
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
2020491 citationsauthor #8
Sex differences in oncogenic mutational processes
202091 citationsauthor #478
Combined burden and functional impact tests for cancer driver discovery using DriverPower
202050 citationsauthor #37
Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
2020351 citationsauthor #74
Cas9 activates the p53 pathway and selects for p53-inactivating mutations
20200 citationsauthor #8
High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations
202059 citationsauthor #107
Publisher Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
20207 citationsauthor #37
Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
20201 citationsauthor #26
Cas9 activates the p53 pathway and selects for p53-inactivating mutations
2020237 citationsauthor #8
Passenger Hotspot Mutations in Cancer
201972 citationsauthor #1
Next-generation characterization of the Cancer Cell Line Encyclopedia
20192,680 citationsauthor #14
RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues
2019423 citationsauthor #4
Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair
20182 citationsauthor #7
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
201830 citationsauthor #18
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles - correction
20180 citationsauthor #21
Comprehensive Characterization of Cancer Driver Genes and Mutations
20181,913 citationsauthor #25
Comprehensive Characterization of Cancer Driver Genes and Mutations
20181,913 citationsauthor #238
Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
20181 citationsauthor #18
Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma.
2018211 citationsauthor #18
Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair
2018166 citationsauthor #9
Comprehensive Characterization of Cancer Driver Genes and Mutations (vol 173, 371.e1, 2018)
2018235 citationsauthor #25
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines.
2018706 citationsauthor #7
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
2018747 citationsauthor #208
Comment on “DNA damage is a pervasive cause of sequencing errors, directly confounding variant identification”
20185 citationsauthor #3
Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
201824 citationsauthor #18
Publisher Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
20182 citationsauthor #18
Pathogenic Germline Variants in 10,389 Adult Cancers.
2018695 citationsauthor #242
Oncogenic Signaling Pathways in The Cancer Genome Atlas.
20182,523 citationsauthor #235
The Immune Landscape of Cancer.
20184,497 citationsauthor #235
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
2018561 citationsauthor #37
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma (vol 32, pg 204, 2017)
20182 citationsauthor #7
A comprehensive analysis of RNA sequences reveals macroscopic somatic clonal expansion across normal tissues
20189 citationsauthor #4
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.
2018653 citationsauthor #8
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
20181,586 citationsauthor #18
Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context
2018229 citationsauthor #211
Publisher Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
20182 citationsauthor #18
Analysis of somatic microsatellite indels identifies driver events in human tumors
2017121 citationsauthor #8
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.
20171,595 citationsauthor #33
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.
2017242 citationsauthor #8
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles
2017470 citationsauthor #21
Recurrent and functional regulatory mutations in breast cancer
2017281 citationsauthor #11
Genetically-Defined Diffuse Large B-Cell Lymphoma Subsets Arise By Distinct Pathogenetic Mechanisms and Predict Outcome
20171 citationsauthor #18
Abstract LB-280: The landscape of somatic microsatellite indels across cancer: detection and identification of driver events
20170 citationsauthor #8
Abstract LB-231: Identifying cancer-related processes in normal tissues via RNA-seq
20171 citationsauthor #4
Large-Scale Uniform Analysis of Cancer Whole Genomes in Multiple Computing Environments
201726 citationsauthor #54
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles-correction
20170 citationsauthor #21
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.
2017134 citationsauthor #114
Discovery and characterization of coding and non-coding driver mutations in more than 2,500 whole cancer genomes
201746 citationsauthor #6
Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair.
2016375 citationsauthor #6
Tumor suppressor genes that escape from X-inactivation contribute to cancer sex bias
2016368 citationsauthor #8
Comprehensive Analyses of Genetic Features Identify Coordinate Signatures in Diffuse Large B-Cell Lymphoma
20150 citationsauthor #10
The Molecular Taxonomy of Primary Prostate Cancer.
20152,656 citationsauthor #93
Mutations driving CLL and their evolution in progression and relapse
20151,001 citationsauthor #16
Supplementary Table 3
2015170 citationsauthor #16
Modeling Unpairing Costs for Fast Computation of the Net Binding Free Energy of an Oligo to an mRNA Target
20140 citationsauthor #1
Supplementary Table 10
20146 citationsauthor #16

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT